- Home
- AUPH vs AHCO Comparison
AUPH vs AHCO Comparison
Compare AUPH & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- AHCO
- Stock Information
- Founded
- AUPH 1993
- AHCO 2012
- Country
- AUPH Canada
- AHCO United States
- Employees
- AUPH N/A
- AHCO N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- AHCO Medical/Nursing Services
- Sector
- AUPH Health Care
- AHCO Health Care
- Exchange
- AUPH Nasdaq
- AHCO Nasdaq
- Market Cap
- AUPH 1.6B
- AHCO 1.3B
- IPO Year
- AUPH 1999
- AHCO N/A
- Fundamental
- Price
- AUPH $16.44
- AHCO $9.68
- Analyst Decision
- AUPH Strong Buy
- AHCO Strong Buy
- Analyst Count
- AUPH 3
- AHCO 5
- Target Price
- AUPH $17.67
- AHCO $13.60
- AVG Volume (30 Days)
- AUPH 2.2M
- AHCO 1.2M
- Earning Date
- AUPH 11-04-2025
- AHCO 11-04-2025
- Dividend Yield
- AUPH N/A
- AHCO N/A
- EPS Growth
- AUPH N/A
- AHCO N/A
- EPS
- AUPH 0.55
- AHCO 0.55
- Revenue
- AUPH $265,808,000.00
- AHCO $3,255,213,000.00
- Revenue This Year
- AUPH $17.33
- AHCO $0.89
- Revenue Next Year
- AUPH $14.31
- AHCO $6.84
- P/E Ratio
- AUPH $29.89
- AHCO $17.68
- Revenue Growth
- AUPH 20.62
- AHCO N/A
- 52 Week Low
- AUPH $6.55
- AHCO $7.11
- 52 Week High
- AUPH $16.47
- AHCO $11.63
- Technical
- Relative Strength Index (RSI)
- AUPH 75.78
- AHCO 55.12
- Support Level
- AUPH $14.94
- AHCO $8.99
- Resistance Level
- AUPH $15.81
- AHCO $10.21
- Average True Range (ATR)
- AUPH 0.61
- AHCO 0.37
- MACD
- AUPH 0.06
- AHCO 0.03
- Stochastic Oscillator
- AUPH 97.97
- AHCO 56.56
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.